News of Note—Apotex tries to kick-start murder probe with $10M reward


> The family of Apotex CEO Barry Sherman is offering a $10 million reward for information leading to an arrest for last year’s murders of Sherman and his wife at their Toronto, Canada, mansion. Story

> WuXi Biologics has started construction on an API facility in Shijiazhuang, China, that will have a 48,000-L bioreactor capacity. Release

> Unither Pharmaceuticals has announced that it has exclusively acquired rights for a technology to develop transmucosal paracetamol solutions for the worldwide market. Release

Suggested Articles

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.

Mylan is the most recent drugmaker facing the FDA's ire over a tainted API that led to a global recall of "sartan"-based drugs last year.

Merck MSD's $1.2 billion production restructuring has fallen on a site in France, where more than 200 manufacturing and R&D jobs will be swept away.